Metal complexes

US10700295B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10700295-B2
Application numberUS-201615760037-A
CountryUS
Kind codeB2
Filing dateSep 9, 2016
Priority dateSep 14, 2015
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides complexes of the formula (L)M(X), in which M is a metal atom selected from copper, silver and gold; L is a carbene ligand; and X is a monoanionic ligand. The complexes are useful as light emitters in the emissive zone of light-emitting devices such as OLEDs. The present invention also provides organometallic complexes which exhibit RASI photoemission, and the use of the same in light-emitting devices such as OLEDs.

First claim

Opening claim text (preview).

The invention claimed is: 1. A complex of the following Formula I: (L)M(X),  (I) in which M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic amide ligand having the formula R′—N—R″ or N in which R′ and R″ are selected from hydrogen and organic groups, which when both organic groups may be the same or different; and represents a cyclic organic group which may contain one or more rings; excluding the compound Ad L-Au-NTf 2 in which Ad L is and Tf is CF 3 —SO 2 —. 2. A complex according to claim 1 , wherein the complex has a neutral overall charge. 3. A complex according to claim 1 , wherein the CAAC ligand L is selected from: A. a compound of Formula IIIa: wherein R a , R b , R c and R d are CH 3 groups, and Ar represents a substituted phenyl group; B. a compound of Formula IIIb: wherein R a and R b are CH 3 groups and Ar represents a substituted phenyl group; and C. the following group of compounds: where R n represents a variable number n of 1-4 substituents, each of which is independently selected from the group comprising hydrogen, alkyl, alkenyl, alkynyl, alkoxy, amino, aryl and heteroaryl. 4. A complex according to claim 1 , wherein the ligand X is selected from: arylamide and diarylamide; carbazolate; di-tert-butylcarbazolate; phenazine; N-methylphenazine; phenothiazine; 3,7-dinitrophenothiazine; acridone; dibenzazepine; and 10,11-dihydrodibenzazepine. 5. A complex according to claim 1 , wherein the ligand X is selected from NHPh and NH(3,5-bis(trifluoromethyl)phenyl), NPh 2 , where Ph=phenyl; carbazolate; 3,6-di-tert-butylcarbazolate; phenazine; N-methylphenazine; phenothiazine; 3,7-dinitrophenothiazine; acridone; dibenzazepine; and 10,11-dihydrodibenzazepine. 6. A light-emitting device comprising an emissive zone capable of emitting light in response to introduced energy, wherein the emissive zone capable of emitting light comprises at least one organometallic complex of Formula I: (L)M(X),  (I) in which A. M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic amide ligand having the formula R′—N—R″ or N in which R′ and R″ are selected from hydrogen and organic groups, which when both organic groups may be the same or different; and represents a cyclic organic group which may contain one or more rings; B. M is a metal atom selected from copper and silver; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic ligand; C. M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic amide ligand having the formula R′—N—R″ or N in which R′ and R″ are selected from hydrogen and organic groups, which when both organic groups may be the same or different; and represents a cyclic organic group which may contain one or more rings; wherein in both options B and C the ligand L is a cyclic compound of Formula III: in which R′ is selected from an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted aryl group, and an optionally substituted heteroaryl group; d=e=f=1 and g=0 so that G has no meaning; D=>CR d R d , where R d =methyl; E=>CH 2 ; and F is >CR f R ff , in which wherein R f and R ff together with the carbon atom C to which they are linked form an unsubstituted adamantylidene group; D. M is a metal atom selected from copper and silver; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic ligand which is a compound of Formula IV [E-Ar] −   (IV) wherein Ar is an optionally substituted aryl or optionally substituted heteroaryl group, and E- is selected from C(R 1 )(R 2 )—, O—, S—, Se—, Te—, N(R)—, P(R)—, As(R)— and Sb(R)—, in which R, R 1 and R 2 are independently chosen from hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted allyl, optionally substituted aryl and optionally substituted heteroaryl; and R, R 1 and R 2 groups, when present, may optionally be directly linked to the Ar moiety by one or more linker species as well as via the said C, N, P, As or Sb atom E. M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic ligand which is a compound of Formula IV [E-Ar] −   (IV) wherein Ar is an optionally substituted aryl or optionally substituted heteroaryl group, and E- is N(R)—, in which R is chosen from hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted allyl, optionally substituted aryl and optionally substituted heteroaryl; and an R group may optionally be directly linked to the Ar moiety by one or more linker species as well as via the said N atom; and excluding the compound Ad L-Au-NTf 2 in which Ad L is and Tf is CF 3 —SO 2 —. 7. A method of preparing complexes of Formula I: (L)M(X),  (I) in which A. M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic amide ligand having the formula R′—N—R″ or N in which R′ and R″ are selected from hydrogen and organic groups, which when both organic groups may be the same or different; and represents a cyclic organic group which may contain one or more rings; B. M is a copper atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic ligand; C. M is a gold atom; L is a cyclic alkyl amino carbene (CAAC) ligand having a saturated cyclic structure in which the atoms of the ring which includes the carbene site consist of carbon atoms and one nitrogen atom; and X is a monoanionic amide ligand having the formula R′—N—R″ or N in which R′ and R″ are selected from hyd

Assignees

Inventors

Classifications

  • H10K85/371Primary

    Metal complexes comprising a group IB metal element, e.g. comprising copper, gold or silver · CPC title

  • characterised by the electroluminescent [EL] layers · CPC title

  • Triplet emission · CPC title

  • C07F1/08Primary

    Copper compounds · CPC title

  • Gold compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10700295B2 cover?
The present invention provides complexes of the formula (L)M(X), in which M is a metal atom selected from copper, silver and gold; L is a carbene ligand; and X is a monoanionic ligand. The complexes are useful as light emitters in the emissive zone of light-emitting devices such as OLEDs. The present invention also provides organometallic complexes which exhibit RASI photoemission, and the use …
Who is the assignee on this patent?
Uea Enterprises Ltd, Cambridge Entpr Ltd
What technology area does this patent fall under?
Primary CPC classification H10K85/371. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).